Effectiveness and Safety of Yiqitongluo Granule for Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2197 participants.

Also called NCT02604654

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,197 participants (enrolled count) (from the registry)
Sponsor
  • Yi Yang Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02604654
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02604654. Allocation not applicable; no masking; primary purpose treatment. Start 2015-12-29 (actual); primary completion 2017-11-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effectiveness and Safety of Yiqitongluo Granule for Stroke
Condition
Stroke
Intervention (Drug)
Yiqitongluo granule
Lead sponsor
Yi Yang (class: other)
Collaborator
Shineway Pharmaceutical Co.,Ltd (class: industry)

Record details

Record id
cardio:ct-nct02604654
Content hash
b58168e3233a5bc5a820bf2ca4b22f7aae3603e625c1ac84434ef9952b44f29c